Cic edizioni internazionali
Functional Neurology

Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study

Original Article, 259 - 264
doi: 10.11138/FNeur/2013.28.4.259
Tag this article
Abstract
Enhanced HTML Full text PDF
Zolpidem has been reported as an “awakening drug” in some patients with disorders of consciousness (DOC).
We here present the results of a prospective openlabel study in chronic DOC patients. Sixty patients (35±15 years; 18 females; mean time since insult ± SD: 4±5.5 years; 31 with traumatic etiology) with a diagnosis of vegetative state/unresponsive wakefulness syndrome (n=28) or minimally conscious state (n=32) were behaviorally assessed using the Coma Recovery Scale-Revised (CRS-R) before and one hour after administration of 10 mg of zolpidem. At the group level, the diagnosis did not change after intake of zolpidem (p=0.10) and CRS-R total scores decreased (p=0.01). Twelve patients (20%) showed improved behaviors and/or CRS-R total scores after zolpidem administration but in only one patient was the diagnosis after zolpidem intake found to show a significant improvement (functional object use), which suggested a change of diagnosis. However, in this patient, a double-blind placebo-controlled trial was performed in order to better specify the effects of zolpidem, but the patient, on this trial, failed to show any clinical improvements.
The present open-label study therefore failed to show any clinically significant improvement (i.e., change of Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study diagnosis) in any of the 60 studied chronic DOC patients

Vol. XXXIII (No. 4) 2018 October/December

  1. Music and neurorehabilitation: Yes, we can!
    Raglio A.
    doi: 10.11138/FNeur/2018.33.4.173
  2. Clinical and neuroimaging spectrum of hyperglycemia-associated chorea-ballism: systematic review and exploratory analysis of case reports
    Gómez-Ochoa S.A., Espín-Chico B.B., Pinilla-Monsalve G.D., Kaas B.M., Téllez-Mosquera L.E.
    doi: 10.11138/FNeur/2018.33.4.175
  3. Recovery of circadian melatonin rhythm after a melatonin holiday in daytime haemodialysis patients on long-term exogenous melatonin
    Sparla S., Koch B.C., Bosma R., Nagtegaal E.
    doi: 10.11138/FNeur/2018.33.4.188
  4. Multiple sclerosis and non-dystrophic myotonias: do they share a common pathophysiology?
    Portaro S., Naro A., Russo M., Bramanti P., Lauria P., D'Aleo G., La Rosa G., Bramanti A., Calabrò R.S.
    doi: 10.11138/FNeur/2018.33.4.194
  5. From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients
    De Bartolo D., Morone G., Lupo A., Aloise F., Baricich A., Di Francesco D., Calderone C., Cisari C., Verdecchia G., Sandrini G., Pistarini C., Antonucci G., Smania N., Paolucci S., Iosa M.
    doi: 10.11138/FNeur/2018.33.4.200
  6. Automated mechanical peripheral stimulation and postural control in subjects with Parkinson’s disease and freezing of gait: a randomized controlled trial
    Prusch J.S., Kleiner A.F.R., Salazar A.P., Pinto C., Marchese R.R., Galli M., Pagnussat A.S.
    doi: 10.11138/FNeur/2018.33.4.206
  7. Is bupropion useful in the treatment of post-stroke thalamic apathy? A case report and considerations
    Aragona B., De Luca R., Piccolo A., Le Cause M., Destro M., Casella C., Filoni S., Calabrò R.S.
    doi: 10.11138/FNeur/2018.33.4.213
  8. TIA patients with higher ABCD3-I scores are prone to a higher incidence of intracranial stenosis, unstable carotid plaques and multiple-vessel involvement
    Yu Q., Miao W., Han J.
    doi: 10.11138/FNeur/2018.33.4.217
  9. Is there a correlation between urological and cardiovascular dysfunction in Parkinson’s disease?
    Brusa L., Rocchi C., Ponzo V., Stanzione P., Finazzi E., Attanasio A.
    doi: 10.11138/FNeur/2018.33.4.225
  10. Cross-cultural adaptation and validation in the Italian population of the wolf motor function test in patients with stroke
    Berardi A., Dhrami L., Tofani M., Valente D., Sansoni J., Galeoto G.
    doi: 10.11138/FNeur/2018.33.4.229
  11. The dawn of algometry: Paolo Mantegazza’s research on pain
    Cani V.
    doi: 10.11138/FNeur/2018.33.4.254
Last Viewed articles: la lista degli ultimi x visitati.
  1. Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study
    Thonnard M., Gosseries O., Demertzi A., Lugo Z., Vanhaudenhuyse A., Bruno M.A., Chatelle C., Thibaut A., Charland-Verville V., Habbal D., Schnakers C., Laureys S.
    doi: 10.11138/FNeur/2013.28.4.259
credits